Holen Sie sich die Stockscreener-App
6.19
1.81%
0.11
Vorhandelsmarkt:
6.28
0.09
+1.45%
Schlusskurs vom Vortag:
$6.08
Offen:
$6.14
24-Stunden-Volumen:
437.24K
Relative Volume:
0.91
Marktkapitalisierung:
$116.16M
Einnahmen:
$107.35M
Nettoeinkommen (Verlust:
$6.84M
KGV:
17.53
EPS:
0.3532
Netto-Cashflow:
$14.64M
1W Leistung:
+26.33%
1M Leistung:
+17.23%
6M Leistung:
-50.16%
1J Leistung:
-52.82%
1-Tages-Spanne:
$6.04
$6.50
1-Wochen-Bereich:
$4.885
$6.50
52-Wochen-Spanne:
$4.54
$22.25
Optimizerx Corp Stock (OPRX) Company Profile
Firmenname
Optimizerx Corp
Sektor
Branche
Telefon
248-651-6558
Adresse
260 CHARLES STREET, WALTHAM, MI
Compare OPRX vs VEEV, BTSG, TEM, HQY, HNGE
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
OPRX
Optimizerx Corp
|
6.19 | 107.34M | 107.35M | 6.84M | 14.64M | 0.3532 |
VEEV
Veeva Systems Inc
|
192.74 | 28.83B | 3.32B | 941.65M | 1.64B | 5.6161 |
BTSG
Brightspring Health Services Inc
|
69.03 | 13.69B | 13.65B | 169.86M | 412.12M | 1.0758 |
TEM
Tempus Ai Inc
|
60.27 | 10.40B | 1.36B | -302.91M | -219.93M | -1.7182 |
HQY
Healthequity Inc
|
95.31 | 7.55B | 1.34B | 230.70M | 440.96M | 2.6695 |
HNGE
Hinge Health Inc
|
84.05 | 6.42B | 646.34M | -512.40M | 202.76M | -6.6871 |
Optimizerx Corp Stock (OPRX) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-01-08 | Herabstufung | RBC Capital Mkts | Outperform → Sector Perform |
| 2024-12-20 | Eingeleitet | Stephens | Equal-Weight |
| 2024-07-25 | Fortgesetzt | B. Riley Securities | Buy |
| 2024-04-04 | Eingeleitet | JMP Securities | Mkt Outperform |
| 2024-01-03 | Eingeleitet | Barclays | Equal Weight |
| 2023-02-02 | Fortgesetzt | B. Riley Securities | Buy |
| 2022-11-01 | Eingeleitet | Stifel | Buy |
| 2022-07-15 | Eingeleitet | SVB Leerink | Outperform |
| 2021-10-18 | Fortgesetzt | B. Riley Securities | Buy |
| 2021-04-13 | Eingeleitet | RBC Capital Mkts | Outperform |
| 2019-01-03 | Eingeleitet | William Blair | Outperform |
Alle ansehen
Optimizerx Corp Aktie (OPRX) Neueste Nachrichten
OptimizeRx Corp. Hits New 52-Week Low at $4.54 Amid Market Struggles - MarketsMojo
OptimizeRx stock rises after launching CopayCue product By Investing.com - Investing.com Australia
OptimizeRx stock rises after launching CopayCue product - Investing.com
OptimizeRx launches CopayCue for prescription savings - Investing.com
OptimizeRx launches CopayCue for prescription savings By Investing.com - Investing.com Canada
OptimizeRx Launches CopayCue™, a Next-Generation Copay Activation Solution Powered by Real-Time Prescribing Intent - The Manila Times
OptimizeRx Launches CopayCue to Deliver Brand Savings Offers at the Point of Prescribing - Quiver Quantitative
OptimizeRx ties copay offers to physician intent at prescribing moment - Stock Titan
OptimizeRx Corporation (OPRX) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade
Stifel reiterates Buy on OptimizeRX stock, cites AI tool launch By Investing.com - Investing.com South Africa
OptimizeRx stock rating maintained at Market Outperform by Citizens - Investing.com Nigeria
OptimizeRx Corporation(NasdaqCM: OPRX) dropped from Russell 2000 Dynamic Index - marketscreener.com
OptimizeRx Corp (OPRX) Institutional Confidence - TradingKey
OptimizeRx Announced the Launch of Natural Language Audience Builder - MarTech Cube
OptimizeRx Launches AI-Powered Natural Language Audience Builder for DSP and Media Planning Platforms - Quiver Quantitative
OptimizeRx Launches Natural Language Audience Builder for Life Sciences DSPs and Agency Media Planning Platforms - Moomoo
Citizens reiterates Market Outperform on OptimizeRX stock at forum By Investing.com - Investing.com Australia
Citizens reiterates Market Outperform on OptimizeRX stock at forum - Investing.com
OptimizeRx Corp (OPRX) Valuation: PE, PB & Fair Value Analysis - TradingKey
OptimizeRx Corp (OPRX) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
OptimizeRx StockAnalyst expectations and recent price levels on a quiet news day - AD HOC NEWS
OptimizeRx Corp (OPRX) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
OptimizeRx Corp (OPRX) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
OptimizeRx Corp (OPRX) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
OptimizeRx's Q4 Beat: A Closer Look at the Numbers - Kavout | AI
OptimizeRx (OPRX) Stock Sees Fair Value Cut As Analysts Reset Growth Expectations - Yahoo Finance
OptimizeRx Corp (OPRX) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
OptimizeRx Corp (OPRX) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
OptimizeRx Corp (OPRX) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
OptimizeRx Expands EHR Advertising Reach With New DSP Integration - qz.com
OptimizeRx (NASDAQ: OPRX) holders add 1M plan shares, reject evergreen - Stock Titan
OptimizeRx Secures $35 Million Senior Credit Facility to Fuel Growth - citybuzz -
ContactThe Lethbridge HeraldNews and Sports from around Lethbridge - FinancialContent
OPRX SEC FilingsOptimizerx Corp 10-K, 10-Q, 8-K Forms - Stock Titan
OptimizeRx: A Good Business That Has Not Yet Earned Back Investor Trust - Investing.com
OptimizeRx (OPRX) grants 34,517 restricted stock units to director - Stock Titan
[Form 4] OptimizeRx Corp Insider Trading Activity - Stock Titan
OptimizeRx (OPRX) director Gregory Wasson awarded 34,517 restricted stock units - Stock Titan
OptimizeRx (NASDAQ: OPRX) director receives 34,517 restricted stock units - Stock Titan
OptimizeRx Corp stock: Q1 earnings beat lifted shares - AD HOC NEWS
OptimizeRx Corp. Sees Valuation Upgrade Amid Positive Financial Trends and High Institutional Confidence - MarketsMojo
OptimizeRx parts ways with Theresa Greco; will serve as advisor through June 15, 2027 - TradingView
OptimizeRx (NASDAQ: OPRX) details CCO exit, $380K salary continuation - Stock Titan
OptimizeRx Corporation Announces Resignation of Theresa Greco as Chief Commercial Officer Role, Effective June 15, 2026 - marketscreener.com
OPRX Technical Analysis | Trend, Signals & Chart Patterns | OPTIMIZERX CORP (NASDAQ:OPRX) - ChartMill
OptimizeRx to Participate in Upcoming Investor Conferences - The Globe and Mail
Where to meet OptimizeRx: investor 1x1s in Boston and Chicago - Stock Titan
OPRX Q1 2026 Earnings: EPS Surges 4017% Above Estimates Amid Strong ExecutionEPS Estimate Trend - The Legal Advocate
OptimizeRx vs. Doximity: Which Digital Health Stock Is the Better Bet? - TradingView
OPRXOptimizeRx Corp Stock Price and Quote - Finviz
OptimizeRx Holds Steady at $4.94 as Traders Await a CatalystFast Moving Stocks - Město Břeclav
Finanzdaten der Optimizerx Corp-Aktie (OPRX)
Umsatz
Nettogewinn
Free Cashflow
ENV
Optimizerx Corp-Aktie (OPRX) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| Stelmakh Edward | Chief Finance & Strat Officer |
Dec 19 '25 |
Sale |
13.51 |
1,388 |
18,752 |
126,830 |
| Silvestro Stephen L | Chief Executive Officer |
Dec 19 '25 |
Option Exercise |
0.00 |
6,546 |
0 |
195,462 |
| Odence-Ford Marion | Chief Legal & Admin Officer |
Dec 19 '25 |
Option Exercise |
0.00 |
3,928 |
0 |
94,526 |
| Besch Doug | Chief Product & Tech Officer |
Dec 19 '25 |
Option Exercise |
0.00 |
1,964 |
0 |
71,536 |
| Odence-Ford Marion | Chief Legal & Admin Officer |
Oct 03 '25 |
Option Exercise |
0.00 |
6,649 |
0 |
92,550 |
| Silvestro Stephen L | Chief Executive Officer |
Oct 03 '25 |
Option Exercise |
0.00 |
6,649 |
0 |
190,536 |
| Silvestro Stephen L | Chief Executive Officer |
Oct 03 '25 |
Sale |
18.75 |
1,620 |
30,375 |
188,916 |
| Stelmakh Edward | Chief Finance & Strat Officer |
Oct 03 '25 |
Option Exercise |
0.00 |
16,623 |
0 |
127,387 |
| Besch Doug | Chief Product & Tech Officer |
Oct 03 '25 |
Option Exercise |
0.00 |
3,325 |
0 |
70,555 |
| Spangler Patrick D | Director |
Aug 28 '25 |
Sale |
17.49 |
11,120 |
194,489 |
44,215 |
1.79%
0.10%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):